Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?

Alexander Tenenbaum email and Enrique Z Fisman email

Cardiovascular Diabetology 2004, 3:10doi:10.1186/1475-2840-3-10

No comments have yet been made on this article

Post a comment


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.